ATG5 and colorectal carcinoma: In addition, multiple Cox regression analyses showed that ATG5 was associated with poor overall survival in females (AHR: 6.61, p < 0.001, Table 2), elderly patients (>60) (AHR: 4.13, p < 0.001), poorly differentiated patients (AHR: 2.75, p < 0.001), patients with AJCC pathological stages I + II (AHR: 3.79, p = 0.010), III + IV (AHR: 2.25, p = 0.021), and T3 + T4 (AHR: 2.77, p = 0.001) and CRC patients without radiation therapy (AHR: 3.29, p < 0.001).